SP

Sunilkumar Patel

Active Director Director DIN 09707909
DIN 09707909 First appointment Aug 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value •••• Premium profile

About Sunilkumar Patel

Data last updated:

Sunilkumar Patel is a Director at Philic Pharma Private Limited (since 2022). The company operates in Chemicals. Philic Pharma Private Limited reported revenue of ₹34 Lakh (FY 2024).

DIN 09707909
Primary Designation Director
Industry Chemicals
First Appointment 18 Aug 2022
Oldest Company Age 4 yrs
Largest company Philic Pharma Private Limited · ₹34 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Philic Pharma Private Limited U24239GJ2022PTC134795
Director18 Aug 20222022₹34 Lakh (FY 2024)Active

Board colleagues of Sunilkumar Patel

Directorship timeline

Open interactive timeline →
Philic Pharma Private Limited
Premium access

Shareholding and investment profile for Sunilkumar Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunilkumar Patel

Sunilkumar Patel currently holds 1 directorship: Philic Pharma Private Limited (Director, since 18 Aug 2022, revenue ₹34 Lakh (FY 2024)).

Sunilkumar Patel was first appointed on 18 Aug 2022 as Director at Philic Pharma Private Limited.

The current boards of Sunilkumar Patel's companies include Anandkumar Haribhai Patel (Philic Pharma Private Limited), Kamleshbhai Arjunkumar Maheshwari (Philic Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available